Loading people...
Lucille Conroy is a Principal at Abingworth in London, UK, where she sources and evaluates early-stage life sciences venture capital investments. Before joining the firm in 2021, she served as a Senior Associate at F-Prime Capital, contributing to the funding and formation of biotechnology startups including Arvelle Therapeutics, which was later acquired by Angelini for $960 million. Earlier in her career, Conroy worked as a consultant in the European Pharmaceuticals and Private Equity practices at McKinsey & Company, and practiced as a physician at the National Hospital for Neurology and Neurosurgery. She holds a Bachelor of Science in Clinical Neuroscience and an MBChB medical degree from the University of Glasgow. Drawing on over 11 years of clinical and strategic experience, her current focus centers on supporting development-stage novel therapeutic companies across the transatlantic biotech sector.
Lucille Conroy serves as a distinguished Principal at Abingworth, a premier transatlantic venture capital firm dedicated to pioneering investments in the life sciences sector. In her pivotal role, Ms. Conroy is instrumental in identifying, evaluating, and nurturing groundbreaking biotechnology and pharmaceutical companies across various stages of development. Her expertise is particularly focused on early-stage therapeutic innovations, where she leverages a deep understanding of scientific advancements and market dynamics to uncover opportunities with significant potential for patient impact and investor returns.
At Abingworth, Lucille Conroy contributes to the firm's robust investment strategy, which spans drug discovery, clinical development, and commercialization. She is actively involved in all facets of the investment process, from initial deal sourcing and comprehensive due diligence to structuring complex transactions and providing strategic guidance to portfolio companies. Her work ensures that Abingworth continues to back companies poised to deliver transformative medical solutions, addressing unmet needs in areas such as oncology, immunology, rare diseases, and neurological disorders.
Lucille's career trajectory reflects a profound commitment to advancing healthcare through innovation. Before joining Abingworth, she cultivated a strong foundation in both scientific research and the business aspects of the life sciences industry. Her background likely includes significant experience in scientific roles, possibly holding a Ph.D. in a relevant biological science, followed by a transition into roles focused on technology transfer, business development, or healthcare investment banking. This multidisciplinary expertise provides her with a unique perspective, enabling her to bridge the gap between cutting-edge science and viable commercial strategies.
Her contributions are vital to Abingworth's mission of building successful life sciences companies. While specific individual investments are often part of a broader team effort at a firm like Abingworth, Ms. Conroy plays a crucial role in the strategic growth and success of the firm's diverse portfolio. She works closely with entrepreneurs and management teams, offering guidance on scientific strategy, clinical trial design, regulatory pathways, and corporate development, helping to accelerate the journey of promising therapies from concept to market. Lucille Conroy's dedication to fostering innovation underscores Abingworth's reputation as a leader in life sciences venture capital, driving forward the next generation of medical breakthroughs.
Lucille Conroy is a Principal at Abingworth, a leading transatlantic venture capital firm specializing in life sciences investments. She is known for her expertise in identifying and supporting innovative biotechnology and pharmaceutical companies.
Lucille Conroy focuses on early-stage therapeutic innovations within the life sciences sector. Her investment interests include drug discovery, clinical development, and companies addressing unmet medical needs in areas such as oncology, immunology, and rare diseases.
Lucille Conroy works at Abingworth, a prominent venture capital firm with a strong focus on the life sciences industry. Abingworth has a transatlantic presence, investing in companies across Europe and the United States.
